Compositions using cycloalkano-quinolone derivatives and their method of
use
    3.
    发明授权
    Compositions using cycloalkano-quinolone derivatives and their method of use 失效
    使用环烷 - 喹诺酮衍生物的组合物及其使用方法

    公开(公告)号:US4049811A

    公开(公告)日:1977-09-20

    申请号:US676269

    申请日:1976-04-12

    CPC classification number: C07D221/08 C07D221/10 C07D221/16

    Abstract: Cycloalkano-quinolone derivatives having anti-microbial activity characterized by the formula: ##STR1##wherein one of R.sub.1 and R.sub.2 designates hydrogen, halogen, nitro, amino, hydroxyl, acylamino, acyloxy, alkoxy or aryloxy and the other taken together with R.sub.3 forms an alkylene bridge containing 2 to 6 carbon atoms, X is hydrogen, lower alkyl, which may be substituted by a member of the group consisting of halogen, hydroxyl, acyloxy, alkoxy, aryloxy, aralkyloxy, mercapto, alkylmercapto, arylmercapto, arylsulfonyl, and alkylsulfonyl, or X is unsubstituted alkenyl including alkadienyl, or alkynyl and Y is hydroxyl, amino or lower alkoxy, and the pharmaceutically acceptable salts thereof.

    Abstract translation: 具有以下结构式表征的抗微生物活性的环烷醇 - 喹诺酮衍生物:其中R 1和R 2之一表示氢,卤素,硝基,氨基,羟基,酰氨基,酰氧基,烷氧基或芳氧基,另一个与R 3一起形成 含有2至6个碳原子的亚烷基桥,X是氢,可以被卤素,羟基,酰氧基,烷氧基,芳氧基,芳烷氧基,巯基,烷基巯基,芳基巯基,芳基磺酰基和烷基磺酰基中的成员所取代的低级烷基 或X为未取代的烯基,包括链二烯基或炔基,Y为羟基,氨基或低级烷氧基,及其药学上可接受的盐。

    Nitroimidazolyl-triazolo-pyridazine compounds
    5.
    发明授权
    Nitroimidazolyl-triazolo-pyridazine compounds 失效
    硝基咪唑基 - 三唑并 - 哒嗪化合物

    公开(公告)号:US4006141A

    公开(公告)日:1977-02-01

    申请号:US601116

    申请日:1975-07-31

    CPC classification number: C07D487/04

    Abstract: Nitroimidazolyl-s-triazolo[4,3-b]pyridazines of the formula: ##STR1## wherein R is hydrogen or lower alkyl optionally substituted in the 2-position by hydroxyl or by lower acyloxy or lower alkoxy;A is hydrogen, halogen, azido, cyano; lower alkyl alkoxy, alkylthio, alkylsulfonyl, carboxyl; lower alkoxycarbonyl, lower alkoxycarbonimidoyl; or hydrazino, carbamoyl, amidino or a carboximidohydrazide group optionally substituted by one or two lower acyl, alkyl or cycloalkyl radicals; orA is a radical of the formula: ##STR2## wherein R.sub.1 and R.sub.2 are, individually, hydrogen or a number of organic radicals or, taken together, can be an alkylene bridge; andR.sub.3 is hydrogen or lower alkyl; or, together with R.sub.2, R.sub.3 can form an alkylene bridge;n is 0 or 1;And the pharmaceutically compatible thereof, possess high in vivo effectiveness as antimicrobials.

    Abstract translation: 具有下式的硝基咪唑基-s-三唑并[4,3-b]哒嗪:其中R是氢或在2-位被羟基或低级酰氧基或低级烷氧基任选取代的低级烷基; A是氢,卤素,叠氮基,氰基; 低级烷基烷氧基,烷硫基,烷基磺酰基,羧基; 低级烷氧基羰基,低级烷氧羰基亚氨基; 或肼基,氨基甲酰基,脒基或任选被一个或两个低级酰基,烷基或环烷基取代的碳代酰肼基; 或者A是下式的基团:其中R 1和R 2分别是氢或多个有机基团,或者一起可以是亚烷基桥; 并且R 3是氢或低级烷基; 或者与R 2一起形成亚烷基桥; N IS 0或1; 并且与药物相容,作为抗病毒药物具有高度的生物有效性。

    3-Nitropyrazole compounds and anti-microbial compositions
    9.
    发明授权
    3-Nitropyrazole compounds and anti-microbial compositions 失效
    3-硝基吡唑化合物和抗微生物组合物

    公开(公告)号:US4172136A

    公开(公告)日:1979-10-23

    申请号:US889594

    申请日:1978-03-23

    CPC classification number: C07D231/16

    Abstract: New 3-nitropyrazole compounds of the formula: ##STR1## wherein R.sub.1 is lower alkyl;R.sub.2 is hydrogen or lower alkyl;R.sub.3 is cyano, carboxyl or lower alkoxycarbonyl or the radical --CO-NR.sub.4 R.sub.5, in whichR.sub.4 is hydrogen or hydroxyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, thiocarbamoyl, ureido, thioureido, hydroxyphenyl, picolyl or is a lower alkyl, alkenyl or cycloalkyl radical substituted, if desired, by a cyano, hydroxyl, pyrrolidino, piperidino, amino, lower alkylamino, lower dialkylamino or lower acylamino substituent andR.sub.5 is a hydrogen atom or a lower alkyl radical orR.sub.4 and R.sub.5 together represent a lower alkylene bridge;And the pharmacologically compatible salts thereof are outstandingly effective as anti-microbial agents, particularly systemically and in the urinary tract.

    Abstract translation: 新的具有下式的3-硝基吡唑化合物:其中R 1是低级烷基; R2是氢或低级烷基; R3是氰基,羧基或低级烷氧基羰基或基团-CO-NR4R5,其中R4是氢或羟基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,硫代氨基甲酰基,脲基,硫脲基,羟基苯基,吡啶甲基或是低级烷基,烯基或环烷基取代 如果需要,通过氰基,羟基,吡咯烷子基,哌啶子基,氨基,低级烷基氨基,低级二烷基氨基或低级酰基氨基取代基,R 5是氢原子或低级烷基,或者R 4和R 5一起代表低级亚烷基桥; 并且其药理学兼容的药物作为抗微生物药剂,特别是在系统性和在尿道感染中是非常有效的。

Patent Agency Ranking